| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
72,082 |
50,163 |
$7.69M |
| D1351 |
Sealant - per tooth |
68,793 |
16,343 |
$885K |
| D1354 |
|
44,196 |
10,956 |
$569K |
| 90832 |
Psychotherapy, 30 minutes with patient |
26,753 |
10,101 |
$542K |
| D1120 |
Prophylaxis - child |
38,592 |
26,721 |
$389K |
| D1206 |
Topical application of fluoride varnish |
46,686 |
32,241 |
$352K |
| D0120 |
Periodic oral evaluation - established patient |
35,372 |
23,219 |
$268K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
10,396 |
6,924 |
$217K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,789 |
4,217 |
$167K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,532 |
1,399 |
$76K |
| 92587 |
|
2,638 |
1,498 |
$26K |
| D1110 |
Prophylaxis - adult |
1,278 |
942 |
$24K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,975 |
955 |
$21K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,837 |
1,041 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
582 |
470 |
$16K |
| 92015 |
Determination of refractive state |
1,433 |
871 |
$14K |
| 99188 |
|
998 |
789 |
$14K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
359 |
276 |
$8K |
| 90834 |
Psychotherapy, 45 minutes with patient |
336 |
130 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
808 |
593 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
290 |
158 |
$5K |
| 86703 |
|
683 |
508 |
$4K |
| 81025 |
|
1,558 |
768 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
139 |
80 |
$4K |
| 0071A |
|
113 |
81 |
$4K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
169 |
81 |
$3K |
| 0001A |
|
146 |
83 |
$3K |
| 99382 |
|
47 |
45 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
542 |
442 |
$3K |
| 92551 |
|
1,013 |
568 |
$3K |
| 99384 |
|
80 |
41 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
637 |
306 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
328 |
253 |
$2K |
| 0002A |
|
97 |
44 |
$2K |
| 99173 |
|
1,733 |
944 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
156 |
90 |
$1K |
| 0072A |
|
47 |
30 |
$1K |
| 81002 |
|
829 |
459 |
$804.45 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
18 |
18 |
$788.32 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
137 |
69 |
$709.06 |
| 96127 |
|
292 |
144 |
$633.11 |
| 90734 |
|
750 |
409 |
$397.64 |
| D0140 |
Limited oral evaluation - problem focused |
67 |
57 |
$361.28 |
| 90651 |
|
309 |
165 |
$306.78 |
| 90619 |
|
207 |
132 |
$150.53 |
| 80305 |
|
23 |
13 |
$102.65 |
| 82962 |
|
71 |
30 |
$83.64 |
| 90715 |
|
210 |
124 |
$73.56 |
| 90461 |
|
656 |
325 |
$70.50 |
| 85018 |
|
36 |
36 |
$62.30 |
| 90686 |
|
147 |
79 |
$39.16 |
| 90620 |
|
399 |
220 |
$10.00 |
| 91300 |
|
336 |
172 |
$1.15 |
| 91307 |
|
174 |
118 |
$0.82 |
| 3044F |
|
605 |
335 |
$0.00 |
| 3074F |
|
315 |
162 |
$0.00 |
| 1036F |
|
2,983 |
1,804 |
$0.00 |
| 3008F |
|
1,996 |
1,091 |
$0.00 |
| 90716 |
|
20 |
13 |
$0.00 |
| D9995 |
|
64 |
55 |
$0.00 |
| 3078F |
|
260 |
128 |
$0.00 |
| 5250F |
|
34 |
13 |
$0.00 |
| 96160 |
|
23 |
13 |
$0.00 |
| 4004F |
|
113 |
65 |
$0.00 |